TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 135 filers reported holding TG THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $675 | +57.3% | 24,476 | +41.9% | 0.00% | 0.0% |
| Q2 2023 | $429 | +65.6% | 17,253 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $259 | +27.0% | 17,253 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $204 | -99.8% | 17,253 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $102,000 | +39.7% | 17,253 | 0.0% | 0.00% | – |
| Q2 2022 | $73,000 | -55.5% | 17,253 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $164,000 | -50.0% | 17,253 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $328,000 | -42.9% | 17,253 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $574,000 | -14.2% | 17,253 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $669,000 | -19.6% | 17,253 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $832,000 | -7.3% | 17,253 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $898,000 | +94.4% | 17,253 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $462,000 | +37.5% | 17,253 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $336,000 | +93.1% | 17,253 | -2.4% | 0.00% | +100.0% |
| Q1 2020 | $174,000 | +17.6% | 17,680 | +32.4% | 0.00% | 0.0% |
| Q4 2019 | $148,000 | +97.3% | 13,349 | 0.0% | 0.00% | – |
| Q3 2019 | $75,000 | -34.8% | 13,349 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $115,000 | +7.5% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $107,000 | +94.5% | 13,349 | 0.0% | 0.00% | – |
| Q4 2018 | $55,000 | -26.7% | 13,349 | 0.0% | 0.00% | – |
| Q3 2018 | $75,000 | -57.4% | 13,349 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $176,000 | -7.4% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $190,000 | +74.3% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $109,000 | -31.0% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $158,000 | +17.9% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $134,000 | -14.1% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $156,000 | +151.6% | 13,349 | 0.0% | 0.00% | – |
| Q4 2016 | $62,000 | -39.8% | 13,349 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $103,000 | +27.2% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $81,000 | -28.9% | 13,349 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $114,000 | +5.6% | 13,349 | +46.9% | 0.00% | 0.0% |
| Q4 2015 | $108,000 | +17.4% | 9,090 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $92,000 | -39.1% | 9,090 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $151,000 | – | 9,090 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |